Study or sub-group | 30 days | 90 days | Odds ratio M–H, fixed (95% CI) | ||
---|---|---|---|---|---|
Eventsa | Total, N | Eventsa | Total, N | ||
Lipid-lowering medication | |||||
Taitel et al (2012)32 | 1014 | 12 136 | 212 | 2162 | 0.84 (0.72 to 0.98) |
Walton et al (2001)35 | 1909 | 13 355 | 545 | 3635 | 0.95 (0.85 to 1.05) |
Antihypertensive medication | |||||
Taitel et al (2012)32 | 3928 | 33 009 | 712 | 5835 | 0.97 (0.89 to 1.06) |
Diabetic medication | |||||
Taitel et al (2012)32 | 1255 | 11 842 | 175 | 1511 | 0.90 (0.76 to 1.07) |
Antidepressant medication | |||||
Taitel et al (2012)32 | 975 | 7017 | 39 | 266 | 0.94 (0.66 to 1.33) |
↵a Events = refers to the number of patients with ≥80% medication adherence. M–H = Mantel–Haenszel. N = the total number of participants evaluated in each arm of the study.